Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.430
+0.150 (6.58%)
At close: Mar 4, 2026, 4:00 PM EST
2.425
-0.005 (-0.21%)
After-hours: Mar 4, 2026, 4:12 PM EST

Century Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
55.5258.4447.3284.2756.4527.21
Short-Term Investments
77.23130.85125.41231.23166.4348.54
Cash & Short-Term Investments
132.75189.29172.74315.5222.8875.75
Cash Growth
-32.99%9.58%-45.25%41.56%194.22%-
Other Current Assets
4.964.734.264.225.283.04
Total Current Assets
137.71194.02176.99319.72228.1578.8
Net Property, Plant & Equipment
70.2890.8592.08111.7369.8224.78
Other Intangible Assets
34.235.21----
Long-Term Investments
-30.8289.151.85135.911.05
Other Long-Term Assets
2.532.322.523.243.492.15
Total Assets
244.72353.22360.69486.54437.38106.78
Accounts Payable
2.633.982.745.457.68.08
Accrued Expenses
11.0316.610.159.846.044.03
Current Portion of Long-Term Debt
---6.51.04-
Unearned Revenue
0.03109.14.377.150-
Other Current Liabilities
8.340.080.580.870.98-
Total Current Liabilities
22.03129.7617.8529.8215.6612.11
Long-Term Debt
---3.748.99.64
Long-Term Leases
41.9948.9646.6638.714.5611.68
Other Long-Term Liabilities
4.374.37111.44111.552.02-
Total Long-Term Liabilities
46.3653.33158.1153.9925.4821.32
Total Liabilities
68.37191.85175.94183.8141.1433.43
Preferred Stock
-----179.76
Common Stock
0.010.010.010.010.010
Additional Paid-in Capital
948.92943.38840.41824.29785.05249.73
Accumulated Other Comprehensive Income
0.140.350.11-2.46-0.65-0
Retained Earnings
-772.71-782.39-655.77-519.1-388.17-292.34
Shareholders' Equity
176.35161.36184.75302.74396.24-106.41
Total Liabilities & Equity
244.72353.22360.69486.54437.38106.78
Total Debt
41.9948.9646.6648.9424.521.32
Net Cash (Debt)
90.76140.33126.08266.56198.3854.44
Net Cash Growth
-35.32%11.30%-52.70%34.37%264.41%-
Net Cash Per Share
1.051.782.134.626.127.28
Book Value
176.35161.36184.75302.74396.24-106.41
Book Value Per Share
2.052.053.115.2412.23-14.22
Tangible Book Value
142.15126.16184.75302.74396.24-106.41
Tangible Book Value Per Share
1.651.603.115.2412.23-14.22
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q